Search Within

Sanjoy Mehta

Formats
  1. Journal Article (6)
  2. Meeting Abstract (2)
Groups
  1. GSK Faculty (8)
  2. Department of Medicine (7)
  3. Sloan Kettering Institute Postdocs (7)
  4. Center for Hematologic Malignancies (5)
  5. Executive Committee, Center for Hematologic Malignancies (5)
  6. Hematologic Malignancies, Division of (5)

More Groups

People
  1. Ralph Garippa (6)
  2. Daniel Zakheim (3)
  3. Elisa De Stanchina (3)
  4. Jesse Barnes (3)
  5. Marco Vincenzo Russo (3)
  6. Omar Abdel-Wahab (3)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (1)
  4. 2022 (1)
  5. 2020 (1)
Publications
  1. Blood (2)
  2. Cell (1)
  3. Nature Cancer (1)
  4. Nature Communications (1)
  5. Science (1)
  6. Science Advances (1)

More Publications

Publishers
  1. American Society of Hematology (2)
  2. Amer Assoc Advancement Science (1)
  3. American Association for the Advancement of Science (1)
  4. Cell Press (1)
  5. Nature Publishing Group (1)
  6. Nature Research (1)

More Publishers

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Uncoupling of Akt and mTOR signaling drives resistance to Akt inhibition in PTEN loss prostate cancers
    Journal Article

    Mao, N.; Lee, Y. S.; Salsabeel, N.; Zhang, Z.; Li, D.; Kaur, H.; Chen, X.; Chang, Q.; Mehta, S.; Barnes, J.; more...
    Science Advances (2025)

    Fulltext@MSK | Save
  • Unique structural configuration of EV-DNA primes Kupffer cell-mediated antitumor immunity to prevent metastatic progression
    Journal Article

    Wortzel, I.; Seo, Y.; Akano, I.; Shaashua, L.; Tobias, G. C.; Hebert, J.; Kim, K. A.; Kim, D.; Dror, S.; Liu, Y.; more...
    Nature Cancer (2024)

    Fulltext@MSK | Save
  • CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradation
    Journal Article

    Quintanal-Villalonga, A.; Kawasaki, K.; Redin, E.; Uddin, F.; Rakhade, S.; Durani, V.; Sabet, A.; Shafer, M.; Karthaus, W. R.; Zaidi, S.; more...
    Signal Transduction and Targeted Therapy (2024)

    Fulltext@MSK | Save
  • TNF-NF-κB-p53 axis restricts in vivo survival of hPSC-derived dopamine neurons
    Journal Article

    Kim, T. W.; Koo, S. Y.; Riessland, M.; Chaudhry, F.; Kolisnyk, B.; Cho, H. S.; Russo, M. V.; Saurat, N.; Mehta, S.; Garippa, R.; more...
    Cell (2024)

    Fulltext@MSK | Save
  • Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127
    Journal Article

    Montoya, S.; Bourcier, J.; Noviski, M.; Lu, H.; Thompson, M. C.; Chirino, A.; Jahn, J.; Sondhi, A. K.; Gajewski, S.; Tan, Y. S.; more...
    Science (2024)

    Fulltext@MSK | Save
  • Synthetic introns identify the novel RNA splicing factor GPATCH8 as required for mis-splicing induced by SF3B1 mutations
    Meeting Abstract

    Benbarche, S.; Pineda, J. M. B.; Galvis, L. B.; Liu, B.; Biswas, J.; Wang, E.; Lyttle, K. A.; Lewis, A. M.; Sarchi, M.; Mehta, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma
    Journal Article

    Erazo, T.; Evans, C. M.; Zakheim, D.; Chu, K. L.; Refermat, A. Y.; Asgari, Z.; Yang, X.; Da Silva Ferreira, M.; Mehta, S.; Russo, M. V.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • ZRSR2 mutation induced minor intron retention drives MDS and diverse cancer predisposition via aberrant splicing of LZTR1
    Meeting Abstract

    Inoue, D.; Polaski, J. T.; Taylor, J.; Castel, P.; Chen, S.; Kobayashi, S.; Hogg, S. J.; Hayashi, Y.; Pineda, J. M. B.; Penson, A. V.; more...
    Blood (2020)

    Fulltext@MSK | Save